Norden Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Norden Group's BIIB Position: Q2 2026 in Review
Norden Group opened a new position in Biogen (BIIB) in Q2 2026: 945 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #670 among its holdings. This is a return to the name: Norden Group previously reported a position in BIIB as recently as Q3 2024.
Norden Group first reported a position in BIIB in Q3 2023 and has held it in 6 quarters since. The position peaked at $552K in Q3 2023. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Norden Group held 945 shares of Biogen worth $204K as of Q2 2026.
- Biogen was a new Norden Group position in Q2 2026.
- Biogen made up 0.02% of Norden Group's portfolio in Q2 2026, its #670 holding.
- Norden Group first reported a position in Biogen in Q3 2023 and has held it in 6 quarters since.
- Norden Group's Biogen position peaked at $552K in Q3 2023.
- 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.